Melbourne, Australia, 14 November 2019: Sienna Cancer Diagnostics Ltd (ASX: SDX) (“Sienna” or “the Company”), advises the results of the resolutions of the 2019 Annual General Meeting (AGM).
As required by section 251AA(2) of the Corporations Act 2001 (Commonwealth) the following statistics are provided in respect of each resolution on the agenda:
| Resolution | For | % | Against | % | Abstain | Resolution Result | |
| 1 | Adoption of Remuneration Report | 119,024,745 | 99.63 | 447,998 | 0.37 | 1,935,046 | Carried |
| 2 | Resolution Withdrawn | ||||||
| 3 | Amendments to the Company Constitution | 121,480,328 | 297,200 | 1,126,032 | Carried | ||
| 4 | Approval of Increased Placement Capacity | 121,480,328 | 297,200 | 1,126,032 | Carried | ||
Note that votes relating to a person who abstains on an item are not counted in determining whether or not the required majority of votes were cast for or against that item.
Comment